Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The efficacy of simvastatin is not influenced by CYP2D6 polymorphism.

× No keyword cloud information.

7 in total

Review 1. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Authors: Russell A Wilke; Debbie W Lin; Dan M Roden; Paul B Watkins; David Flockhart; Issam Zineh; Kathleen M Giacomini; Ronald M Krauss
Journal: Nat Rev Drug Discov Date: 2007-11 Impact factor: 84.694

Review 2. Pharmacogenetics of response to statins.

Authors: Issam Zineh
Journal: Curr Atheroscler Rep Date: 2007-09 Impact factor: 5.113

Review 3. Genomic view of factors leading to plaque instability.

Authors: Sonny Dandona; Robert Roberts
Journal: Curr Cardiol Rep Date: 2009-07 Impact factor: 2.931

4. Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients.

Authors: An Wang; Bang-Ning Yu; Chen-Hui Luo; Zhi-Rong Tan; Gan Zhou; Lian-Sheng Wang; Wei Zhang; Zhi Li; Jie Liu; Hong-Hao Zhou
Journal: Eur J Clin Pharmacol Date: 2005-01-14 Impact factor: 2.953

Review 5. Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions.

Authors: QiPing Feng; Russell A Wilke; Tesfaye M Baye
Journal: Pharmacogenomics Date: 2012-04 Impact factor: 2.533

6. The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6.

Authors: Thomayant Prueksaritanont; Bennett Ma; Nathan Yu
Journal: Br J Clin Pharmacol Date: 2003-07 Impact factor: 4.335

Review 7. Pharmacogenetics of lipid diseases.

Authors: Jose M Ordovas
Journal: Hum Genomics Date: 2004-01 Impact factor: 4.639

7 in total